| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 13 Nov 2026 | SCHEDULE 13G/A |
| 04 Nov 2026 | 10-Q |
| 29 Oct 2026 |
8-K: Other Events
Virtual Investor Day October 29, 2026 Nasdaq: XFOR Exhibit 99.1 |
| 19 Oct 2026 |
Form 4: Craig Adam R, Director
Bought 4,600 shares ($11.9K) |
| 08 Oct 2026 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +3 more
- Strengthens Financial Flexibility with Access to Funding for Corporate and Commercial Activities - |
| 07 Oct 2026 | SCHEDULE 13G/A |
| 05 Oct 2026 |
Form 4: Kirske David, Chief Financial Officer
Sold 11,767 shares ($33.7K) |
| 01 Oct 2026 | 144 |
| 21 Sep 2026 | SCHEDULE 13G |
| 09 Sep 2026 |
8-K: Other Events
Corporate Presentation September 2026 Nasdaq: XFOR EXHIBIT 99.1 |
| 08 Sep 2026 |
8-K: Other Events
- FDA Agrees to Reduced Sample Size for the Global 4WARD Phase 3 Chronic Neutropenia Trial - |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 |
Form 4: Volpone John, President
Sold 24,576 shares ($109K) |
| 13 Aug 2026 |
Form 4: Craig Adam R, Director
Sold 47,436 shares ($211K) |
| 13 Aug 2026 | 144 |
| 13 Aug 2026 | 144 |
| 06 Aug 2026 | 10-Q |
| 30 Jul 2026 | SCHEDULE 13G |
Loading...